{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:03:50Z","timestamp":1792717430335,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T00:00:00Z","timestamp":1161648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s10549-006-9394-6","type":"journal-article","created":{"date-parts":[[2006,10,23]],"date-time":"2006-10-23T13:02:47Z","timestamp":1161608567000},"page":"87-91","source":"Crossref","is-referenced-by-count":108,"title":["Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging"],"prefix":"10.1007","volume":"104","author":[{"given":"Leilani","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Pans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Paridaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Westhovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wildiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Berteloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Van Limbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Weltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Van den Bogaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"De Smet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Rose","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,24]]},"reference":[{"key":"9394_CR1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"The ATAC Trialists\u2019 Group","year":"2005","unstructured":"The ATAC Trialists\u2019 Group (2005) Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for breast cancer. Lancet 365:60\u201362","journal-title":"Lancet"},{"key":"9394_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa032312","volume":"349","author":"P Goss","year":"2003","unstructured":"Goss P, Ingle J, Martino S et al (2003) A randomized trial of letrozole in postmenopausal women after 5\u00a0years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349:1\u201310","journal-title":"N Engl J Med"},{"key":"9394_CR3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","volume":"350","author":"RC Coombes","year":"2004","unstructured":"Coombes RC, Hall E, Gibson LJ et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081\u20131092","journal-title":"N Engl J Med"},{"key":"9394_CR4","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"The Breast International Group (BIG) 1\u201398 Collaborative Group","year":"2005","unstructured":"The Breast International Group (BIG) 1\u201398 Collaborative Group (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747\u20132757","journal-title":"N Engl J Med"},{"key":"9394_CR5","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1200\/JCO.2005.04.120","volume":"23","author":"F Boccardo","year":"2005","unstructured":"Boccardo F, Rubagotti A, Puntoni M et al (2005) Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 23:5138\u20135147","journal-title":"J Clin Oncol"},{"key":"9394_CR6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"R Jakesz","year":"2005","unstructured":"Jakesz R, Jonat W, Gnant M et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2\u00a0years\u2019 adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455\u2013462","journal-title":"Lancet"},{"key":"9394_CR7","doi-asserted-by":"crossref","first-page":"900s","DOI":"10.1158\/1078-0432.900s.11.2","volume":"11","author":"J Ingle","year":"2005","unstructured":"Ingle J (2005) Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings. Clin Cancer Res 11:900s\u20139005s","journal-title":"Clin Cancer Res"},{"key":"9394_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1677\/erc.0.0060325","volume":"6","author":"PE Goss","year":"1999","unstructured":"Goss PE (1999) Risk versus benefits in the clinical application of aromatase inhibitors. Endocrine-Related Cancer 6:325\u2013332","journal-title":"Endocrine-Related Cancer"},{"key":"9394_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000087282","volume":"69","author":"W Gradishar","year":"2005","unstructured":"Gradishar W (2005) Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women. Oncology 69:1\u20139","journal-title":"Oncology"},{"key":"9394_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/01.cco.0000180434.31991.bf","volume":"17","author":"L Morales","year":"2005","unstructured":"Morales L, Neven P, Paridaens R (2005) Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting. Curr Opin Oncol 17:559\u2013565","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"9394_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2005.05.005","volume":"57","author":"J Geisler","year":"2006","unstructured":"Geisler J, Lonning PE (2006) Aromatase inhibitors as adjuvant treatment of breast cancer. Crit Rev Oncol Hematol 57(1):53\u201361","journal-title":"Crit Rev Oncol Hematol"},{"key":"9394_CR12","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/j.seminoncol.2006.03.022","volume":"33","author":"A Brufsky","year":"2006","unstructured":"Brufsky A (2006) Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update. Semin Oncol 33:S13","journal-title":"Semin Oncol"},{"key":"9394_CR13","doi-asserted-by":"crossref","unstructured":"Coombes R, Paridaens R, Jassem C et al (2006) First mature analysis of the Intergroup Exemestane Study. J Clin Oncol ASCO Annual Proceedings 24 (Suppl 18):(Abstr LBA527)","DOI":"10.1200\/jco.2006.24.18_suppl.lba527"},{"key":"9394_CR14","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2001.19.10.2767","volume":"19","author":"P Donnellan","year":"2001","unstructured":"Donnellan P, Douglas S, Cameron D, Leonard R (2001) Aromatase inhibitors and arthralgia. J Clin Oncol 19:2767","journal-title":"J Clin Oncol"},{"key":"9394_CR15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00001813-200409000-00003","volume":"15","author":"L Morales","year":"2004","unstructured":"Morales L, Neven P, Timmerman D et al (2004) Acute effects of tamoxifen and third generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anti-Cancer Drugs 15:753\u2013760","journal-title":"Anti-Cancer Drugs"},{"key":"9394_CR16","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/art.21364","volume":"52","author":"D Felson","year":"2005","unstructured":"Felson D, Cummings S (2005) Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheumatism 52:2594\u20132598","journal-title":"Arthritis Rheumatism"},{"key":"9394_CR17","doi-asserted-by":"crossref","unstructured":"The Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists\u2019 Group (2006) Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 7(8):633\u2013643","DOI":"10.1016\/S1470-2045(06)70767-7"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9394-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-006-9394-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9394-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T13:30:13Z","timestamp":1683639013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-006-9394-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,24]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["9394"],"URL":"https:\/\/doi.org\/10.1007\/s10549-006-9394-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,24]]}}}